Enliven Therapeutics (NASDAQ:ELVN) released its Q4 earnings on Tuesday, March 3, 2026 at 04:05 PM.
Here’s what’s important from the earnings announcement.
Earnings
Enliven Therapeutics missed estimated earnings by -6.67%, reporting an EPS of $-0.48 versus an estimate of $-0.45.
Revenue was down $0 from the same period last year.
Earnings History Overview
During the previous quarter, the company beat …